How is the ImmunityBio Inc today?

The ImmunityBio Inc today is trading in the down by -1.91% at 2.05.

How has ImmunityBio Inc performed historically?

The ImmunityBio Inc is currently trading down -1.91% on an intraday basis in the past week the index fell -17.67%. The index has been down -38.99% in the past quarter and fell -74.12% in the past year. You can view this in the overview section.

What is ImmunityBio Inc Annual Revenue?

ImmunityBio Inc Annual Revenue rose 2,270.58%, in the last year to $14.74 M. Its sector's average revenue growth for the last fiscal year was 7.49%.

What is ImmunityBio Inc Annual Net Profit?

ImmunityBio Inc Annual Net Profit rose 29.09% in the last year to $413.56 M. Its sector's average net profit growth for the last fiscal year was -32.45%.

What is ImmunityBio Inc Price to Earning Ratio?

ImmunityBio Inc Price to Earning Ratio is -4.37, which is negative.

What is ImmunityBio Inc Stock Price?

ImmunityBio Inc Stock Price fell 74.12% and underperformed its sector by 78.08% in the past year.

What is ImmunityBio Inc Quarterly Revenue?

ImmunityBio Inc Quarterly Revenue rose 5,333.09% YoY to $7.55 M. Its sector's average revenue growth YoY for the quarter was 5.23%.

What is ImmunityBio Inc Quarterly Net profit?

ImmunityBio Inc Quarterly Net profit rose 74.65% YoY to $59.16 M. Its sector's average net profit growth YoY for the quarter was -29.63%.

What is ImmunityBio Inc Mutual Fund Holding?

ImmunityBio Inc Mutual Fund Holding decreased by 0.35% in the last quarter to 6.82.

What is ImmunityBio Inc Interest Coverage Ratio?

ImmunityBio Inc Interest Coverage Ratio is -2.14, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).

What is ImmunityBio Inc Institutional Holding?

ImmunityBio Inc Institutional Holding increased by 0.01% in the last quarter to 9.69.

ImmunityBio Inc XNAS: IBRX

ImmunityBio Inc Live Share Price Today, Share Analysis and Chart

Name: ImmunityBio Inc: Is Infosys Ltd. worth buying?
Item: ImmunityBio Inc
Rating: 0.55158325
Author: Trendlyne DVM scores

about

ImmunityBio Inc is an integrated clinical-stage biotechnology company discovering, developing, and commercializing next-generation immuno- and cellular therapies that bolster the natural immune system to drive and sustain an immune response. Its plat...

2.05 -0.04 (-1.91%)

New 52W Low in past week

1.0M XNAS Volume

High vol.+loss this week

XNAS 09 May, 2025 10:39 AM (EDT)

Board Meeting

The board meeting for ImmunityBio Inc is scheduled for today, for the purpose of ImmunityBio Inc First Quarter Earnings Results for 2025 See details

Not Eligible

Expensive Valuation

1.3 / 100

Technically Bearish

20.7 / 100

1Yr Price target upside is 534%

4 analysts

ImmunityBio Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

ImmunityBio Inc Live Share Price Today, Share Analysis and Chart

ImmunityBio Inc is an integrated clinical-stage biotechnology company discovering, developing, and commercializing next-generation immuno- and cellular therapies that bolster the natural immune system to drive and sustain an immune response. Its plat...

New 52W Low in past week

High vol.+loss this week

SWOT Analysis

ImmunityBio Inc Live Price Chart

ImmunityBio Inc FAQ

How is ImmunityBio Inc today?

ImmunityBio Inc today is trading in the red, and is down by -1.91% at 2.05.

How has ImmunityBio Inc performed historically?

ImmunityBio Inc is currently trading down -1.91% on an intraday basis. In the past week the stock fell -17.67%. stock has been down -38.99% in the past quarter and fell -74.12% in the past year. You can view this in the overview section.